Treatment of atrial fibrillation: time for change?
Campbell
T J
TJ
St Vincent's Hospital, Sydney.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000628:therapy; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013015:Sotalol / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D004071:Digitalis Glycosides; D010975:Platelet Aggregation Inhibitors; D004077:Digoxin; D013015:Sotalol; D011342:Procainamide